Pharmaceutical

Filter

Current filters:

None

Popular Filters

7001 to 7025 of 7191 results

Domain partners with RusNano on drug production in Russia

07-03-2012

Russian state nanotechnology corporation RusNano and Domain Associates, a US venture fund, are to invest…

Domain AssociatesEuropeFinancialPharmaceuticalRusNano

Forest Labs and Pierre Fabre's levomilnacipran positive in Ph III

07-03-2012

US drugmaker Forest Laboratories (NYSE: FRX) and France-based Pierre Fabre have announced positive top-line…

Forest LaboratorieslevomilnacipranNeurologicalPharmaceuticalPierre FabreResearch

Merck KGaA 4th-qtr profits triple, but miss expectations

07-03-2012

German drug major Merck KGaA (MRK: DE) posted a massive improvement in fourth-quarter 2011 net profit,…

FinancialMerck KGaAPharmaceutical

FDA nod for Discovery Labs Surfaxin for RDS

07-03-2012

US specialty drugmaker Discovery Laboratories (Nasdaq: DSCO) saw its shares rocker 30% to $4.88 in after-hours…

Discovery LaboratoriesNorth AmericaPharmaceuticalRegulationRespiratory and PulmonarySurfaxin

Roche has options beyond Illumina

07-03-2012

Speaking at the companys annual meeting, Swiss drug maj'or Roche (ROG: SIX) chairman Franz Humer said:…

FinancialIlluminaMergers & AcquisitionsPharmaceuticalRoche

CNS disease therapies take 35% longer to develop than other drugs, says Tufts CSDD

06-03-2012

Drugs developed to treat central nervous system (CNS) diseases take 35% longer to complete clinical trials…

NeurologicalPharmaceuticalRegulationResearch

Takeda's Edarbi set to be gold standard for hypertension

06-03-2012

Based on clinical data and the opinions of interviewed thought leaders, Edarbi (azilsartan medoxomil),…

Cardio-vascularDiovanEdarbiGlobalMarkets & MarketingNovartisPharmaceuticalTakeda Pharmaceuticals

Dundee, GSK and Wellcome Trust collaborate for neglected diseases

06-03-2012

The University of Dundee, UK, has received over ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������£10…

FinancialGlaxoSmithKlinePharmaceuticalResearchTropical diseases

UK researchers find potential new target for rheumatoid arthritis

06-03-2012

Scientists at the Newcastle University, UK, in work funded by Arthritis Research UK, have discovered…

Anti-Arthritics/RheumaticsPharmaceuticalResearch

US House Bill will establish inspection parity, improve US drug supply

06-03-2012

Ranking US Congress Member Henry Waxman, Health Subcommittee Ranking Member Frank Pallone, Representative…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

Abcam to buy Epitomics for $170 million

06-03-2012

In a second acquisition within six months, UK-based protein research tools supplier Abcam (AIM: ABC)…

AbcamEpitomics InternationalFinancialMergers & AcquisitionsPharmaceutical

Strong Ph III results for Lundbeck alcohol dependence drug Selincro

06-03-2012

Danish CNS drug specialist Lundbeck (LUN DC) announced positive results of a Phase III clinical program…

LundbeckNeurologicalPharmaceuticalResearchSelincro

Agenus expands deal with GlaxoSmithKline; Nuron in-licenses vaccines

06-03-2012

US biotech firm Agenus (Nasdaq: AGEN) says it has amended the QS-21 license and manufacturing agreement…

AgenusAkshaya BioBiotechnologyGlaxoSmithKlineLicensingNuron BiotechPharmaceuticalVaccines

New Zealand to fund new cancer drugs Tykerb and Votrient

05-03-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, says it is funding two new targeted cancer…

Asia-PacificGlaxoSmithKlineOncologyPharmaceuticalPricingRegulationTykerbVotrient

Senior appointments as Sanofi and Onyx

05-03-2012

French drug major Sanofi (Euronext: SAN) has named former Bayer executive Jean-Luc Lowinski as senior…

ManagementOnyx PharmaceuticalsPharmaceuticalSanofi

EMA updates market authorization holder requirements

05-03-2012

Pharmaceutical regulator the European Medicines Agency said yesterday that it has published an updated…

BiotechnologyEuropePharmaceuticalRegulation

Proximagen boasts strong cash balance, updates on R&D

05-03-2012

UK-based CNS and inflammatory diseases specialist Proximagen (AIM: PRX) has announced its unaudited preliminary…

FinancialPharmaceuticalProximagenResearch

SciClone drops oral mucositis candidate SCV-07

05-03-2012

USA-based SciClone Pharmaceuticals (Nasdaq: SCLN) said on Friday that results from a pre-planned interim…

Asia-PacificMarkets & MarketingOncologyPharmaceuticalResearchSciClone Pharma

UCB sees strong showing from core products in 2011

05-03-2012

Belgian drugmaker UCB (UCB: BR) announced consolidated 2011 financial results, showing that revenue increased…

FinancialPharmaceuticalUCB

Illumina fails in patent litigation with LadaTech

04-03-2012

USA-based Illumina (Nasdaq: ILMN) says that a federal jury in Wilmington, Delaware, found that certain…

IlluminaLadaTechLegalNorth AmericaPatentsPharmaceuticalRoche

Abbott unit snaps up LIMS distributors

04-03-2012

As part of a series of strategic moves to build its laboratory information management system (LIMS) business…

Abbott LaboratoriesMergers & AcquisitionsPharmaceuticalSTARLIMS

7001 to 7025 of 7191 results

Back to top